# Accessorized Pre-Filled Syringe to Autoinjector Pharmacokinetic Bridging Study in Anifrolumab

> **NCT05339100** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 180 (actual)

## Conditions studied

- Healthy Participants Study

## Interventions

- **DRUG:** Anifrolumab
- **DEVICE:** Autoinjector
- **DEVICE:** Accessorized Pre-Filled Syringe

## Key facts

- **NCT ID:** NCT05339100
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-22
- **Primary completion:** 2023-04-13
- **Final completion:** 2023-04-13
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2023-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05339100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05339100, "Accessorized Pre-Filled Syringe to Autoinjector Pharmacokinetic Bridging Study in Anifrolumab". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05339100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*